DIVISLAB's weekly performance was relatively stable, with a modest return of 0.05% amidst high volatility of 20.14%. The stock outperformed its peers, including DRREDDY, SUNPHARMA, and CIPLA, which all saw negative returns. However, the Sharpe Ratio of 0.02 indicates that the return was not sufficient to compensate for the risk taken. The Max Drawdown of -1.57% suggests that the stock was relatively risky this week.

[Volatility: 20.14%]